Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.03B | 21.58B | 19.24B | 19.68B | 16.94B | 8.09B |
Gross Profit | 3.61B | 4.82B | 3.64B | 3.17B | 2.47B | 1.43B |
EBITDA | 2.57B | 3.82B | 2.82B | 2.46B | 1.85B | 1.04B |
Net Income | 1.64B | 2.39B | 1.80B | 1.61B | 1.16B | 579.87M |
Balance Sheet | ||||||
Total Assets | 28.37B | 32.62B | 29.95B | 27.91B | 29.32B | 22.14B |
Cash, Cash Equivalents and Short-Term Investments | 7.70B | 6.90B | 9.71B | 9.58B | 10.64B | 10.46B |
Total Debt | 0.00 | 2.00B | 0.00 | 0.00 | 0.00 | 2.96M |
Total Liabilities | 9.60B | 12.99B | 10.24B | 9.33B | 11.91B | 5.39B |
Stockholders Equity | 18.76B | 19.63B | 19.71B | 18.58B | 17.41B | 16.75B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.44B | 1.24B | -507.45M | 628.73M | 4.73B |
Operating Cash Flow | 0.00 | -1.53B | 1.52B | -459.20M | 1.37B | 5.16B |
Investing Cash Flow | 0.00 | -815.86M | -291.83M | -55.35M | -759.39M | -363.40M |
Financing Cash Flow | 0.00 | -366.85M | -1.10B | -541.03M | -439.26M | -525.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥33.94B | 8.82 | 10.31% | 3.32% | 4.01% | 5.67% | |
76 Outperform | €64.61B | 13.13 | 7.14% | 1.97% | 6.81% | 10.94% | |
73 Outperform | ¥89.92B | 6.62 | 4.16% | 9.44% | 25.41% | ||
72 Outperform | ¥20.13B | 7.93 | 5.05% | -4.51% | -4.46% | ||
72 Outperform | ¥93.92B | 8.75 | 5.07% | 31.96% | 26.36% | ||
71 Outperform | ¥319.85B | 29.76 | 4.03% | 3.04% | 2.87% | 2.48% | |
67 Neutral | €8.11B | 20.84 | 6.46% | 2.90% | 1.89% | -38.99% |